Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Net Cash Provided by (Used in) Operating Activities [Abstract]
Net Income (Loss)	$ (17,297)	$ (29,609)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	35,152	34,643
Amortization of debt issuance costs and discount	1,718	1,409
Paid-in-kind interest	2,064	1,491
Total derivative loss, net of cash settlements	582	3,139
Share of net income from joint venture, net of cash dividends received	(6,597)	851
Gain on sale of business	(7,154)	0
Share-based compensation expense	2,347	2,058
Deferred income taxes	(477)	(1,531)
Other	(658)	(776)
Changes in operating assets and liabilities:
Accounts receivable	(3,957)	335
Inventories	(1,916)	9,692
Other operating assets	2,873	8,223
Accounts payable	1,794	5,240
Income taxes receivable and payable, net	(1,078)	(576)
Other operating liabilities	2,739	5,747
Net cash provided by operating activities	4,389	23,890
Cash flows from investing activities
Acquisition of property, plant and equipment	(15,352)	(16,292)
Proceeds from sale of property, plant, and equipment	266	2,876
Proceeds from Sale of Businesses	17,000	0
Net cash provided by (used in) investing activities	1,914	(13,416)
Cash flows from financing activities
Proceeds from long-term debt	38,000	52,000
Repayments of long-term debt	(75,320)	(55,522)
Proceeds from sale-leaseback of equipment	8,324	0
Proceeds from sale-leaseback of land and buildings	16,863	0
Repayments of financing obligations	(492)	0
Cash paid for debt issuance costs	(746)	(55)
Proceeds from short-term debt	0	3,648
Other	(2,262)	(1,276)
Net cash used in financing activities	(15,633)	(1,205)
Effect of exchange rate changes on cash flows	(124)	(287)
Net change in cash and cash equivalents	(9,454)	8,982
Cash and cash equivalents at beginning of period	21,903	12,808
Cash cash equivalents at end of period	$ 12,449	$ 21,790